Literature DB >> 9708633

The oxygen fixation hypothesis: a reevaluation.

D Ewing1.   

Abstract

The oxygen fixation hypothesis (OFH), developed in the late 1950s, is widely regarded as the most satisfactory explanation of why oxygen is a radiation sensitizer. Central to this hypothesis is the explicit belief that DNA lesions (originally called "target lesions") that are produced by x-rays with the chemical participation of oxygen pose a special threat to cell survival because these lesions cannot be chemically restored to an undamaged state. According to this hypothesis, oxygen sensitizes because these "nonrestorable" lesions ultimately increase the amount of stable DNA damage--and thus the extent of lethality--from a give dose. Using three wild-type strains of Escherichia coli, the maximum insignificant dose (MID, the maximum dose that does not reduce the survival from 1.0) was measured. The MID values are clearly strain dependent. This result is inconsistent with the OFH since the production of "nonrestorable" DNA-O2 radicals should not be affected by the genetic identity of the irradiated cell. By focusing solely on rapid events in radiation chemistry, this hypothesis does not address any role that might be played by enzymatic DNA repair. In fact, if enzymatic repair is successful, then the issue of chemical restorability is not relevant to lethality or to radiation sensitization by oxygen. Overall, these results emphasize that the OFH does not satisfactorily explain why oxygen is a sensitizer. Although the basic chemistry proposed in the OFH is undoubtedly correct, the hypothesis does not explain why the reaction products pose a special risk to the cell. Attention must also be given to enzymatic DNA repair and to its success.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9708633     DOI: 10.1097/00000421-199808000-00008

Source DB:  PubMed          Journal:  Am J Clin Oncol        ISSN: 0277-3732            Impact factor:   2.339


  21 in total

Review 1.  Cellular and molecular mechanisms underlying oxygen-dependent radiosensitivity.

Authors:  Chao Liu; Qun Lin; Zhong Yun
Journal:  Radiat Res       Date:  2015-05-04       Impact factor: 2.841

Review 2.  Inside the hypoxic tumour: reprogramming of the DDR and radioresistance.

Authors:  Katheryn Begg; Mahvash Tavassoli
Journal:  Cell Death Discov       Date:  2020-08-18

Review 3.  Emergence of rationally designed therapeutic strategies for breast cancer targeting DNA repair mechanisms.

Authors:  Bryan P Rowe; Peter M Glazer
Journal:  Breast Cancer Res       Date:  2010-04-30       Impact factor: 6.466

4.  The Role of Humidity and Oxygen Level on Damage to DNA Induced by Soft X-rays and Low-Energy Electrons.

Authors:  Elahe Alizadeh; Léon Sanche
Journal:  J Phys Chem C Nanomater Interfaces       Date:  2013-07-09       Impact factor: 4.126

Review 5.  Ion Transport and Radioresistance.

Authors:  Bastian Roth; Stephan M Huber
Journal:  Rev Physiol Biochem Pharmacol       Date:  2022       Impact factor: 5.545

Review 6.  Hypoxia Imaging As a Guide for Hypoxia-Modulated and Hypoxia-Activated Therapy.

Authors:  Jeffrey R Brender; Yu Saida; Nallathamby Devasahayam; Murali C Krishna; Shun Kishimoto
Journal:  Antioxid Redox Signal       Date:  2022-01       Impact factor: 8.401

7.  A mechanistic investigation of the oxygen fixation hypothesis and oxygen enhancement ratio.

Authors:  David Robert Grimes; Mike Partridge
Journal:  Biomed Phys Eng Express       Date:  2015-12-04

Review 8.  Assessing and monitoring intratumor heterogeneity in glioblastoma: how far has multimodal imaging come?

Authors:  Natalie R Boonzaier; Sara G M Piccirillo; Colin Watts; Stephen J Price
Journal:  CNS Oncol       Date:  2015-10-26

9.  Incorporating oxygenation levels in analytical DNA-damage models-quantifying the oxygen fixation mechanism.

Authors:  Frank Van den Heuvel; Anna Vella; Francesca Fiorini; Mark Brooke; Mark A Hill; Tim Maughan
Journal:  Phys Med Biol       Date:  2021-07-09       Impact factor: 3.609

10.  Transcription factor networks of oligodendrogliomas treated with adjuvant radiotherapy or observation inform prognosis.

Authors:  Jonathan So; Yasin Mamatjan; Gelareh Zadeh; Kenneth Aldape; Fabio Y Moraes
Journal:  Neuro Oncol       Date:  2021-05-05       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.